Prabhat Mishra
Title | Assistant Professor |
---|
Institution | University of Arkansas for Medical Sciences |
---|
Department | Anesthesiology, College of Medicine |
---|
Division | Anesthesiology Pediatric Anesthes |
---|
Address | 800 Marshall Street Mail Slot # 203 Little Rock AR 72202
|
---|
vCard | Download vCard |
---|
|
|
|
Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Faculty can login to make corrections and additions.
Don't see publications published under other names? Login to add alternative names.
-
Mishra N, Sharma M, Mishra P, Nisha R, Singh P, Pal RR, Singh N, Singh S, Maurya P, Pant S, Mishra PR, Saraf SA. Transporter targeted-carnitine modified pectin-chitosan nanoparticles for inositol hexaphosphate delivery to the colon: An in silico and in vitro approach. Int J Biol Macromol. 2024 Apr; 263(Pt 2):130517. PMID: 38423444.
-
Tiwari P, Shukla RP, Yadav K, Panwar D, Agarwal N, Kumar A, Singh N, Bakshi AK, Marwaha D, Gautam S, Rai N, Mishra PR. Exploring nanocarriers as innovative materials for advanced drug delivery strategies in onco-immunotherapies. J Mol Graph Model. 2024 May; 128:108702. PMID: 38219505.
-
Singh N, Marwaha D, Gautam S, Rai N, Tiwari P, Sharma M, Shukla RP, Mugale MN, Kumar A, Mishra PR. Surface-Modified Lyotropic Crystalline Nanoconstructs Bearing Doxorubicin and Buparvaquone Target Sigma Receptors through pH-Sensitive Charge Conversion to Improve Breast Cancer Therapy. Biomacromolecules. 2023 12 11; 24(12):5780-5796. PMID: 38006339.
-
Tiwari P, Shukla RP, Yadav K, Singh N, Marwaha D, Gautam S, Bakshi AK, Rai N, Kumar A, Sharma D, Mishra PR. Dacarbazine-primed carbon quantum dots coated with breast cancer cell-derived exosomes for improved breast cancer therapy. J Control Release. 2024 Jan; 365:43-59. PMID: 37935257.
-
Sharma M, Panwar D, Tiwari P, Kumar A, Gautam S, Marwaha D, Rai N, Singh N, Bakshi AK, Agarwal N, Singh NKC, Mitra K, Prajapati VM, Mishra PR. Immobilized doxorubicin and ribociclib carbamate linkers encaged in surface modified cubosomes spatially target tumor reductive environment to enhance antitumor efficacy. Biomater Adv. 2023 Dec; 155:213672. PMID: 37976833.
-
Tiwari P, Yadav K, Shukla RP, Gautam S, Marwaha D, Sharma M, Mishra PR. Surface modification strategies in translocating nano-vesicles across different barriers and the role of bio-vesicles in improving anticancer therapy. J Control Release. 2023 11; 363:290-348. PMID: 37714434.
-
Panwar D, Thakor P, Sharma M, Bakshi AK, Bhavana V, Srivastava V, Mishra PR, Singh SB, Mehra NK. Hyaluronic acid-engineered Bcl-2 inhibitor nanocrystals for site-specific delivery to breast tumor cells. Nanomedicine (Lond). 2023 06; 18(15):1005-1023. PMID: 37530043.
-
Marwaha D, Gautam S, Singh N, Rai N, Sharma M, Tiwari P, Shukla RP, Urandur S, Banala VT, Mugale MN, Kumar A, Mishra PR. Synergistic delivery of Imatinib through multifunctional nano-crystalline capsules, in response to redox environment for improved breast cancer therapy. Colloids Surf B Biointerfaces. 2023 Jun; 226:113316. PMID: 37086687.
-
Gautam S, Marwaha D, Singh N, Rai N, Sharma M, Tiwari P, Urandur S, Shukla RP, Banala VT, Mishra PR. Self-Assembled Redox-Sensitive Polymeric Nanostructures Facilitate the Intracellular Delivery of Paclitaxel for Improved Breast Cancer Therapy. Mol Pharm. 2023 04 03; 20(4):1914-1932. PMID: 36848489.
-
Sharma M, Mittapelly N, Banala VT, Urandur S, Gautam S, Marwaha D, Rai N, Singh N, Gupta A, Mitra K, Mishra PR. Correction To "Amalgamated Microneedle Array Bearing Ribociclib-Loaded Transfersomes Eradicate Breast Cancer via CD-44 Targeting". Biomacromolecules. 2022 Dec 09. PMID: 36493357.
-
Sardar A, Gautam S, Sinha S, Rai D, Tripathi AK, Dhaniya G, Mishra PR, Trivedi R. Nanoparticles of naturally occurring PPAR-? inhibitor betulinic acid ameliorates bone marrow adiposity and pathological bone loss in ovariectomized rats via Wnt/?-catenin pathway. Life Sci. 2022 Nov 15; 309:121020. PMID: 36191680.
-
Sharma M, Bakshi AK, Mittapelly N, Gautam S, Marwaha D, Rai N, Singh N, Tiwari P, Agarwal N, Kumar A, Mishra PR. Recent updates on innovative approaches to overcome drug resistance for better outcomes in cancer. J Control Release. 2022 06; 346:43-70. PMID: 35405165.
-
Sharma M, Mittapelly N, Banala VT, Urandur S, Gautam S, Marwaha D, Rai N, Singh N, Gupta A, Mitra K, Mishra PR. Amalgamated Microneedle Array Bearing Ribociclib-Loaded Transfersomes Eradicates Breast Cancer via CD44 Targeting. Biomacromolecules. 2022 03 14; 23(3):661-675. PMID: 34978424.
-
Ramachandran R, Bhosale V, Reddy H, Atam V, Faridi M, Fatima J, Shukla V, Khan ZA, Khan H, Singh V, Negi MPS, Srivastava M, Srivastava AK, Tripathi CB, Ghosh N, Majumdar N, Tripathi RK, Rath SK, Mishra PR, Sharma S, Kundu TK. Phase III, Randomized, Double-blind, Placebo controlled trial of Efficacy, Safety and Tolerability of Antiviral drug Umifenovir vs Standard care of therapy in non-severe COVID-19 patients. Int J Infect Dis. 2022 Feb; 115:62-69. PMID: 34801738.
-
Singh PK, Raman N, Singh VK, Akhtar S, Mishra P, Sharma S. Cone-beam Computed Tomographic Evaluation of the Anatomical Changes of Temporomandibular Joint Use of Pre-post Dentures: A Time-control Study. J Contemp Dent Pract. 2020 Dec 01; 21(12):1354-1360. PMID: 33893258.
This graph shows the total number of publications by year, by first, middle/unknown, or last author.
To see the data from this visualization as text, click here.
Year | Publications |
---|
2020 | 1 | 2021 | 1 | 2022 | 4 | 2023 | 7 | 2024 | 2 |
To return to the timeline, click here.
|
Mishra's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Derived automatically based on a person's publications. Keywords from attributed publications are matched to keywords from the MeSH. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|